SynteractHCR Adds Another Three Senior Executives To Management Team With Both U.S. and International Clinical Trials Operations Experience

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Irrimax Receives FDA Clearance for Irrisept

"This new clearance from the FDA further solidifies Irrisept as the market leader in wound irrigation," said Mark Alvarez, CEO of Irrimax.

April 19, 2017

SynteractHCR, a full-service, international contract research organization (CRO), has appointed three new senior-level managers to its leadership team to ensure internationally-cohesive, enhanced support for sponsors.

SynteractHCR notes their newest senior executives include: Heather Davis, executive director of U.S. Project Management; Zia Haque, executive director, Clinical Data Management, and John Whitaker, Ph.D. as executive director, Biostatistics. All will report to Marlo M. Vasquez, vice president, U.S. Operations at SynteractHCR.

Heather Davis has been hired as executive director of the U.S. Project Management organization. With 20+ years in project management and clinical operations, Davis will provide leadership, strategic direction and oversight to the U.S. Project Management group. She will work with counterparts in Europe to ensure SynteractHCR continues to drive a global strategy supporting sponsors’ needs. Most recently she was vice president of Project Management for the Oncology division at Novella Clinical, where she was responsible for developing strategic priorities, mentoring and coaching teams to ensure operational excellence and providing executive oversight for clients.

Zia Haque will serve as executive director, Clinical Data Management at SynteractHCR. Haque draws on 20+ years of in-depth, progressive experience in the areas of global clinical data management, client relationship management, proposal and business development support, building and leading global teams and implementing process improvements in the CRO industry. Most recently he was global head of data management, Real World & Late Phase Research at QuintilesIMS, where he led efforts at creating a data management team focused on observational research and introducing fit for purpose EDC technology.

Dr. John Whitaker joins SynteractHCR as executive director, Biostatistics. As such, he will be responsible for leading the Biostatistics group, including planning resources and activities to achieve departmental goals and maintaining a close working relationship with other functional groups and clients to ensure coordinated operational delivery. Most recently, Whitaker was a statistical consultant providing regulatory support, data analysis and statistical programming, protocol design and data quality review. He also served as senior vice president, Clinical Innovation and vice president, Biostatistics and Scientific Programming at INC Research. He has a doctorate in administrative engineering systems, advanced statistics from Union College.

“At SynteractHCR, we are committed to providing the highest levels of partnership and service to sponsors worldwide. In offering our international customers guidance across the spectrum of Phase I-IV clinical studies, as well as specific services from regulatory to project management, data management at biostatistics, we rely on our leaders in the industry to address their unique project needs,” said Wendel Barr, CEO. “We welcome John, Heather and Zia to our rapidly growing team dedicated to providing superior clinical trial management support, insights and service.”

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.